‌

US Patent 11266641 Formulations of a somatostatin modulator

Patent 11266641 was granted and assigned to Crinetics Pharmaceuticals on March, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Crinetics Pharmaceuticals

0

Current Assignee

Crinetics Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Ian Yates0

Kyle Kyburz0

Clayton Tyler0

Gerald Burke0

Hannah Bulovsky0

Date of Patent

March 8, 2022

0

Patent Application Number

174684400

Date Filed

September 7, 2021

0

Patent Citations

US Patent 10875839 Somatostatin modulators and uses thereof

US Patent 10351547 Somatostatin modulators and uses thereof

US Patent 10464918 Process of making somatostatin modulators

US Patent 10597377 Somatostatin modulators and uses thereof

0

US Patent 10696689 Somatostatin modulators and uses thereof

US Patent 10889561 Process of making somatostatin modulators

Patent Citations Received

US Patent 11414397 Somatostatin modulators and uses thereof

Patent Primary Examiner

Raymond J. Henley, III

0

Patent abstract

Described herein are formulations of a somatostatin modulator, methods of making such formulations, and methods of using such formulations in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11266641 Formulations of a somatostatin modulator

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.